1.The significance of C-reactive protein levels in maternal serum with outcome of tocolysis.
Chung Ok PARK ; Tae Gyu PARK ; Chul Sung BAE ; Yoon Kee PARK ; Sung Ho LEE ; Wun Yong CHUNG
Korean Journal of Obstetrics and Gynecology 1991;34(6):781-789
No abstract available.
C-Reactive Protein*
;
Tocolysis*
2.C-reactive Protein and Metabolic Syndrome.
Hyun Chul LEE ; Hyeung Jin KIM
Journal of Korean Society of Endocrinology 2002;17(2):152-157
No abstract available.
C-Reactive Protein*
3.A study of quantitative analysis of serum C-reactive protein in normal pregnancy.
Korean Journal of Obstetrics and Gynecology 1991;34(6):772-780
No abstract available.
C-Reactive Protein*
;
Pregnancy*
4.Comparison of C-reactive protein serum levels among in-pat ients with acute exacerbation of Schizophrenia at the Veterans Memorial Medical Center (VMMC) Department of Psychiatry from August 2013 – July 2015
Hannah Martella M. Maddatu- Pajarillo
The Philippine Journal of Psychiatry 2021;2(1-2):60-
BACKGROUND:
Several immunological abnormalities, such as decreased T-cell interleukin-2 production and abnormal cellular and humoral reactivity to neurons, had been associated with patients who have schizophrenia. Several researches have been conducted to study the correlation of elevated inflammatory markers with the symptomatology of schizophrenia.
OBJECTIVES:
The aim of this study is to determine the levels of C-reactive protein, which is a general marker for infection and inflammation, in patients with Schizophrenia in acute exacerbation and compare these to the levels of C-reactive protein in patients with Schizophrenia in remission.
METHODS:
A cross-sectional study was carried out on in-patients at the Veterans Memorial Medical Center Department of Psychiatry. Serum levels of C-reactive protein in adult patients were determined during an acute exacerbation of Schizophrenia. These were compared to Creactive protein levels of patients with Schizophrenia in remission. PASW Statistics 18 (SPSS) was used for data management, tabulation and analysis.
RESULTS:
Cases of eighty-six (86) patients, seen by the principal investigator during OPD consults were reviewed, 43 of which had Schizophrenia in Acute Exacerbation and also 43 of patients were in Remission. The mean CRP level of patients in acute exacerbation was 7.05 mg/L (SD=0.23), which was higher than the mean CRP level of patients in remission at 5.30 mg/L (SD=0.30).
CONCLUSION
This study demonstrated that a stronger association exists between an acute exacerbation of Schizophrenia and elevated C-Reactive protein, in the absence of another systemic inflammatory disease when compared to the association between levels of Creactive protein in patients with Schizophrenia, in remission. This finding could pave the way for initiation of studies examining whether adjunct treatment of anti-inflammatory drugs with anti-psychotics will improve disease outcome.
C-Reactive Protein
;
Schizophrenia
5.The Role and Clinical Significance of High-Sensitivity C-Reactive Protein in Cardiovascular Disease.
Korean Circulation Journal 2012;42(3):151-153
No abstract available.
C-Reactive Protein
;
Cardiovascular Diseases
6.Clinical Study of C-Reactive Protein in Neonatal Bacterial Infections.
Kyung Shin KIM ; Myung Sung MOON ; Jin CHOI ; Keun Soo LEE
Journal of the Korean Pediatric Society 1983;26(9):866-871
No abstract available.
Bacterial Infections*
;
C-Reactive Protein*
7.Performance Evaluation of the ichroma SMART Analyzer in Measuring C-reactive Protein and Procalcitonin Levels.
John Hoon RIM ; Hyo Jun AHN ; Kwang Kuk YOON ; Hye Ryun KIM ; Young Ah KIM ; Hwan Sub LIM ; Jongha YOO
Laboratory Medicine Online 2016;6(1):19-24
BACKGROUND: For monitoring infection and inflammation episodes, biomarkers of host response, such as C-reactive protein (CRP) and procalcitonin (PCT), are now being recognized as useful tools in the diagnostic process. We aimed at evaluating the analytical performance of the recently developed semi-automated ichroma SMART system (Boditech Med Inc., Korea), which allows measurements of both CRP and PCT. METHODS: We evaluated the analytical performance of the ichroma SMART system and the agreement between its results and the laboratory standards for CRP and PCT measurements. The precision and linearity as well as the method of measurement were compared to the DxC 800 (Beckman Coulter, USA) for CRP and to the VIDAS (bioMerieux SA, France) for PCT, according to corresponding CLSI guidelines. Additionally, we evaluated the carryover rates between specimens. RESULTS: The total precision (% CV) of the ichroma SMART system in measuring low, middle, and high level controls (level 1, 2, 3) was 6.32%, 5.75%, and 3.56% for CRP, and 8.07%, 6.24%, and 6.53% for PCT. In the linearity test, R2 was 0.9997 and 0.9982 for CRP (0.1-336.8 mg/L) and PCT (0.05-60.91 ng/mL), respectively. Good correlation was observed between ichroma SMART and DxC 800 for CRP (r=0.997), and between ichroma SMART and VIDAS for PCT (r=0.992). Carry-over effect was 0.02% for CRP and 0.04% for PCT. CONCLUSIONS: The ichroma SMART system showed an adequate performance and appeared to be a suitable clinical analyzer with a simple operating procedure for the measurement of CRP and PCT.
Biomarkers
;
C-Reactive Protein*
;
Inflammation
10.C-reactive protein (CRP) in rheumatic diseases
Journal of Medical and Pharmaceutical Information 2001;1():25-28
C-reactive protein (CRP) is an acute-phase protein in normal serum which increases significantly with tissue necrosis due to inflammation. To discover the level of protein C-reactive as a screening parameter for inflammatory diseases and rheumatic diseases, the CRP latex quick test was performed in 172 patients who were treated at the Rheumatology Dep. Bach mai Hospital from 2/1998 to 2/1999. The result shown that 100% patients with rheumatic fever had CRP positively, as well as 85,4% patients with rheumatics arthritis, 75% patients with connective disorders, 70% patients with ankylosing spondilitis and 20% patients with osteoarthritis. CRP is a valuable screening test in acute rheumatic arthritis as a routine diagnostic test, especially with the group of patients with rheumatic fever. However, this examination has an adequate sensitivity and specificity as well as erythrocyte sedimentation rate (ESR).
Rheumatic Diseases
;
C-Reactive Protein